cro.directory
← Compare landing

Protheragen vs Tigermed

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryProtheragenTigermed
SummarySpecialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • High-Throughput Screening
  • Medicinal Chemistry
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Microbiology Services
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
  • Radiopharmaceutical
Indications
  • Metabolic
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Ophthalmology
  • Gastroenterology
Phases
  • Preclinical (General)
  • Phase I
  • Discovery
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Real-World Evidence (RWE) / Registries
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
LocationsData not yet provided.
  • Headquarters, Hangzhou, Zhejiang, China
  • Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Protheragen alternatives · Tigermed alternatives

Markdown mirror: /compare/obesityscientific/tigermedgrp.md